aluates Reports

$ 0.0

Automative

Global Viral Vectors Market Research Report 2025

Published Date: September 2025

Report Code: QYRE-Auto-9H2963

Global Viral Vectors Market Size Status and Forecast 2021 2027

BUY CHAPTERS

Global Viral Vectors Market Research Report 2025

Code: QYRE-Auto-9H2963

Report

September 2025

Pages:94

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

BioReliance

Cobra Biologics

Oxford BioMedica

Uniqure

FinVector

Molmed

MassBiologics

Richter-Helm

FUJIFILM Diosynth Biotechnologies

Lonza

Aldevron

Eurogentec S.A

Cell and Gene Therapy Catapult

Biovian

VGXI

PlasmidFactory

Thermo Fisher Scientific (Brammer Bio)

Viral Vectors Market

The global market for Viral Vectors was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

North American market for Viral Vectors is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Viral Vectors is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The global market for Viral Vectors in Cancers is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global companies of Viral Vectors include BioReliance, Cobra Biologics, Oxford BioMedica, UniQure, FinVector, MolMed, MassBiologics, Richter-Helm, FUJIFILM Diosynth Biotechnologies, Lonza, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for Viral Vectors, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Viral Vectors.

The Viral Vectors market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Viral Vectors market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Viral Vectors companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Viral Vectors Market Report

Report Metric	Details
Report Name	Viral Vectors Market
Segment by Type	Retroviral Vectors Lentiviral Vectors Adenoviral Vectors Herpes Simplex Virus Vectors Chimeric Viral Vectors Others
Segment by Application	Cancers Inherited Disorders Viral Infections Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	BioReliance, Cobra Biologics, Oxford BioMedica, UniQure, FinVector, MolMed, MassBiologics, Richter-Helm, FUJIFILM Diosynth Biotechnologies, Lonza, Aldevron, Eurogentec, Cell and Gene Therapy Catapult, Biovian, Thermo Fisher Scientific (Brammer Bio), VGXI, PlasmidFactory
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Viral Vectors company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Viral Vectors Market report?

Ans: The main players in the Viral Vectors Market are BioReliance, Cobra Biologics, Oxford BioMedica, UniQure, FinVector, MolMed, MassBiologics, Richter-Helm, FUJIFILM Diosynth Biotechnologies, Lonza, Aldevron, Eurogentec, Cell and Gene Therapy Catapult, Biovian, Thermo Fisher Scientific (Brammer Bio), VGXI, PlasmidFactory

What are the Application segmentation covered in the Viral Vectors Market report?

Ans: The Applications covered in the Viral Vectors Market report are Cancers, Inherited Disorders, Viral Infections, Others

What are the Type segmentation covered in the Viral Vectors Market report?

Ans: The Types covered in the Viral Vectors Market report are Retroviral Vectors, Lentiviral Vectors, Adenoviral Vectors, Herpes Simplex Virus Vectors, Chimeric Viral Vectors, Others

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Viral Vectors Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Retroviral Vectors

1.2.3 Lentiviral Vectors

1.2.4 Adenoviral Vectors

1.2.5 Herpes Simplex Virus Vectors

1.2.6 Chimeric Viral Vectors

1.2.7 Others

1.3 Market by Application

1.3.1 Global Viral Vectors Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Cancers

1.3.3 Inherited Disorders

1.3.4 Viral Infections

1.3.5 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Viral Vectors Market Perspective (2020-2031)

2.2 Global Viral Vectors Growth Trends by Region

2.2.1 Global Viral Vectors Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Viral Vectors Historic Market Size by Region (2020-2025)

2.2.3 Viral Vectors Forecasted Market Size by Region (2026-2031)

2.3 Viral Vectors Market Dynamics

2.3.1 Viral Vectors Industry Trends

2.3.2 Viral Vectors Market Drivers

2.3.3 Viral Vectors Market Challenges

2.3.4 Viral Vectors Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Viral Vectors Players by Revenue

3.1.1 Global Top Viral Vectors Players by Revenue (2020-2025)

3.1.2 Global Viral Vectors Revenue Market Share by Players (2020-2025)

3.2 Global Viral Vectors Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Viral Vectors Revenue

3.4 Global Viral Vectors Market Concentration Ratio

3.4.1 Global Viral Vectors Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Viral Vectors Revenue in 2024

3.5 Global Key Players of Viral Vectors Head office and Area Served

3.6 Global Key Players of Viral Vectors, Product and Application

3.7 Global Key Players of Viral Vectors, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Viral Vectors Breakdown Data by Type

4.1 Global Viral Vectors Historic Market Size by Type (2020-2025)

4.2 Global Viral Vectors Forecasted Market Size by Type (2026-2031)

5 Viral Vectors Breakdown Data by Application

5.1 Global Viral Vectors Historic Market Size by Application (2020-2025)

5.2 Global Viral Vectors Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Viral Vectors Market Size (2020-2031)

6.2 North America Viral Vectors Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Viral Vectors Market Size by Country (2020-2025)

6.4 North America Viral Vectors Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Viral Vectors Market Size (2020-2031)

7.2 Europe Viral Vectors Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Viral Vectors Market Size by Country (2020-2025)

7.4 Europe Viral Vectors Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Viral Vectors Market Size (2020-2031)

8.2 Asia-Pacific Viral Vectors Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Viral Vectors Market Size by Region (2020-2025)

8.4 Asia-Pacific Viral Vectors Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Viral Vectors Market Size (2020-2031)

9.2 Latin America Viral Vectors Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Viral Vectors Market Size by Country (2020-2025)

9.4 Latin America Viral Vectors Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Viral Vectors Market Size (2020-2031)

10.2 Middle East & Africa Viral Vectors Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Viral Vectors Market Size by Country (2020-2025)

10.4 Middle East & Africa Viral Vectors Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 BioReliance

11.1.1 BioReliance Company Details

11.1.2 BioReliance Business Overview

11.1.3 BioReliance Viral Vectors Introduction

11.1.4 BioReliance Revenue in Viral Vectors Business (2020-2025)

11.1.5 BioReliance Recent Development

11.2 Cobra Biologics

11.2.1 Cobra Biologics Company Details

11.2.2 Cobra Biologics Business Overview

11.2.3 Cobra Biologics Viral Vectors Introduction

11.2.4 Cobra Biologics Revenue in Viral Vectors Business (2020-2025)

11.2.5 Cobra Biologics Recent Development

11.3 Oxford BioMedica

11.3.1 Oxford BioMedica Company Details

11.3.2 Oxford BioMedica Business Overview

11.3.3 Oxford BioMedica Viral Vectors Introduction

11.3.4 Oxford BioMedica Revenue in Viral Vectors Business (2020-2025)

11.3.5 Oxford BioMedica Recent Development

11.4 UniQure

11.4.1 UniQure Company Details

11.4.2 UniQure Business Overview

11.4.3 UniQure Viral Vectors Introduction

11.4.4 UniQure Revenue in Viral Vectors Business (2020-2025)

11.4.5 UniQure Recent Development

11.5 FinVector

11.5.1 FinVector Company Details

11.5.2 FinVector Business Overview

11.5.3 FinVector Viral Vectors Introduction

11.5.4 FinVector Revenue in Viral Vectors Business (2020-2025)

11.5.5 FinVector Recent Development

11.6 MolMed

11.6.1 MolMed Company Details

11.6.2 MolMed Business Overview

11.6.3 MolMed Viral Vectors Introduction

11.6.4 MolMed Revenue in Viral Vectors Business (2020-2025)

11.6.5 MolMed Recent Development

11.7 MassBiologics

11.7.1 MassBiologics Company Details

11.7.2 MassBiologics Business Overview

11.7.3 MassBiologics Viral Vectors Introduction

11.7.4 MassBiologics Revenue in Viral Vectors Business (2020-2025)

11.7.5 MassBiologics Recent Development

11.8 Richter-Helm

11.8.1 Richter-Helm Company Details

11.8.2 Richter-Helm Business Overview

11.8.3 Richter-Helm Viral Vectors Introduction

11.8.4 Richter-Helm Revenue in Viral Vectors Business (2020-2025)

11.8.5 Richter-Helm Recent Development

11.9 FUJIFILM Diosynth Biotechnologies

11.9.1 FUJIFILM Diosynth Biotechnologies Company Details

11.9.2 FUJIFILM Diosynth Biotechnologies Business Overview

11.9.3 FUJIFILM Diosynth Biotechnologies Viral Vectors Introduction

11.9.4 FUJIFILM Diosynth Biotechnologies Revenue in Viral Vectors Business (2020-2025)

11.9.5 FUJIFILM Diosynth Biotechnologies Recent Development

11.10 Lonza

11.10.1 Lonza Company Details

11.10.2 Lonza Business Overview

11.10.3 Lonza Viral Vectors Introduction

11.10.4 Lonza Revenue in Viral Vectors Business (2020-2025)

11.10.5 Lonza Recent Development

11.11 Aldevron

11.11.1 Aldevron Company Details

11.11.2 Aldevron Business Overview

11.11.3 Aldevron Viral Vectors Introduction

11.11.4 Aldevron Revenue in Viral Vectors Business (2020-2025)

11.11.5 Aldevron Recent Development

11.12 Eurogentec

11.12.1 Eurogentec Company Details

11.12.2 Eurogentec Business Overview

11.12.3 Eurogentec Viral Vectors Introduction

11.12.4 Eurogentec Revenue in Viral Vectors Business (2020-2025)

11.12.5 Eurogentec Recent Development

11.13 Cell and Gene Therapy Catapult

11.13.1 Cell and Gene Therapy Catapult Company Details

11.13.2 Cell and Gene Therapy Catapult Business Overview

11.13.3 Cell and Gene Therapy Catapult Viral Vectors Introduction

11.13.4 Cell and Gene Therapy Catapult Revenue in Viral Vectors Business (2020-2025)

11.13.5 Cell and Gene Therapy Catapult Recent Development

11.14 Biovian

11.14.1 Biovian Company Details

11.14.2 Biovian Business Overview

11.14.3 Biovian Viral Vectors Introduction

11.14.4 Biovian Revenue in Viral Vectors Business (2020-2025)

11.14.5 Biovian Recent Development

11.15 Thermo Fisher Scientific (Brammer Bio)

11.15.1 Thermo Fisher Scientific (Brammer Bio) Company Details

11.15.2 Thermo Fisher Scientific (Brammer Bio) Business Overview

11.15.3 Thermo Fisher Scientific (Brammer Bio) Viral Vectors Introduction

11.15.4 Thermo Fisher Scientific (Brammer Bio) Revenue in Viral Vectors Business (2020-2025)

11.15.5 Thermo Fisher Scientific (Brammer Bio) Recent Development

11.16 VGXI

11.16.1 VGXI Company Details

11.16.2 VGXI Business Overview

11.16.3 VGXI Viral Vectors Introduction

11.16.4 VGXI Revenue in Viral Vectors Business (2020-2025)

11.16.5 VGXI Recent Development

11.17 PlasmidFactory

11.17.1 PlasmidFactory Company Details

11.17.2 PlasmidFactory Business Overview

11.17.3 PlasmidFactory Viral Vectors Introduction

11.17.4 PlasmidFactory Revenue in Viral Vectors Business (2020-2025)

11.17.5 PlasmidFactory Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

BioReliance

Cobra Biologics

Oxford BioMedica

Uniqure

FinVector

Molmed

MassBiologics

Richter-Helm

FUJIFILM Diosynth Biotechnologies

Lonza

Aldevron

Eurogentec S.A

Cell and Gene Therapy Catapult

Biovian

VGXI

PlasmidFactory

Thermo Fisher Scientific (Brammer Bio)

List of Tables

Table 1. Global Viral Vectors Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Retroviral Vectors

Table 3. Key Players of Lentiviral Vectors

Table 4. Key Players of Adenoviral Vectors

Table 5. Key Players of Herpes Simplex Virus Vectors

Table 6. Key Players of Chimeric Viral Vectors

Table 7. Key Players of Others

Table 8. Global Viral Vectors Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 9. Global Viral Vectors Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 10. Global Viral Vectors Market Size by Region (2020-2025) & (US$ Million)

Table 11. Global Viral Vectors Market Share by Region (2020-2025)

Table 12. Global Viral Vectors Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 13. Global Viral Vectors Market Share by Region (2026-2031)

Table 14. Viral Vectors Market Trends

Table 15. Viral Vectors Market Drivers

Table 16. Viral Vectors Market Challenges

Table 17. Viral Vectors Market Restraints

Table 18. Global Viral Vectors Revenue by Players (2020-2025) & (US$ Million)

Table 19. Global Viral Vectors Market Share by Players (2020-2025)

Table 20. Global Top Viral Vectors Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Viral Vectors as of 2024)

Table 21. Ranking of Global Top Viral Vectors Companies by Revenue (US$ Million) in 2024

Table 22. Global 5 Largest Players Market Share by Viral Vectors Revenue (CR5 and HHI) & (2020-2025)

Table 23. Global Key Players of Viral Vectors, Headquarters and Area Served

Table 24. Global Key Players of Viral Vectors, Product and Application

Table 25. Global Key Players of Viral Vectors, Date of Enter into This Industry

Table 26. Mergers & Acquisitions, Expansion Plans

Table 27. Global Viral Vectors Market Size by Type (2020-2025) & (US$ Million)

Table 28. Global Viral Vectors Revenue Market Share by Type (2020-2025)

Table 29. Global Viral Vectors Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 30. Global Viral Vectors Revenue Market Share by Type (2026-2031)

Table 31. Global Viral Vectors Market Size by Application (2020-2025) & (US$ Million)

Table 32. Global Viral Vectors Revenue Market Share by Application (2020-2025)

Table 33. Global Viral Vectors Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 34. Global Viral Vectors Revenue Market Share by Application (2026-2031)

Table 35. North America Viral Vectors Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 36. North America Viral Vectors Market Size by Country (2020-2025) & (US$ Million)

Table 37. North America Viral Vectors Market Size by Country (2026-2031) & (US$ Million)

Table 38. Europe Viral Vectors Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 39. Europe Viral Vectors Market Size by Country (2020-2025) & (US$ Million)

Table 40. Europe Viral Vectors Market Size by Country (2026-2031) & (US$ Million)

Table 41. Asia-Pacific Viral Vectors Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 42. Asia-Pacific Viral Vectors Market Size by Region (2020-2025) & (US$ Million)

Table 43. Asia-Pacific Viral Vectors Market Size by Region (2026-2031) & (US$ Million)

Table 44. Latin America Viral Vectors Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 45. Latin America Viral Vectors Market Size by Country (2020-2025) & (US$ Million)

Table 46. Latin America Viral Vectors Market Size by Country (2026-2031) & (US$ Million)

Table 47. Middle East & Africa Viral Vectors Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 48. Middle East & Africa Viral Vectors Market Size by Country (2020-2025) & (US$ Million)

Table 49. Middle East & Africa Viral Vectors Market Size by Country (2026-2031) & (US$ Million)

Table 50. BioReliance Company Details

Table 51. BioReliance Business Overview

Table 52. BioReliance Viral Vectors Product

Table 53. BioReliance Revenue in Viral Vectors Business (2020-2025) & (US$ Million)

Table 54. BioReliance Recent Development

Table 55. Cobra Biologics Company Details

Table 56. Cobra Biologics Business Overview

Table 57. Cobra Biologics Viral Vectors Product

Table 58. Cobra Biologics Revenue in Viral Vectors Business (2020-2025) & (US$ Million)

Table 59. Cobra Biologics Recent Development

Table 60. Oxford BioMedica Company Details

Table 61. Oxford BioMedica Business Overview

Table 62. Oxford BioMedica Viral Vectors Product

Table 63. Oxford BioMedica Revenue in Viral Vectors Business (2020-2025) & (US$ Million)

Table 64. Oxford BioMedica Recent Development

Table 65. UniQure Company Details

Table 66. UniQure Business Overview

Table 67. UniQure Viral Vectors Product

Table 68. UniQure Revenue in Viral Vectors Business (2020-2025) & (US$ Million)

Table 69. UniQure Recent Development

Table 70. FinVector Company Details

Table 71. FinVector Business Overview

Table 72. FinVector Viral Vectors Product

Table 73. FinVector Revenue in Viral Vectors Business (2020-2025) & (US$ Million)

Table 74. FinVector Recent Development

Table 75. MolMed Company Details

Table 76. MolMed Business Overview

Table 77. MolMed Viral Vectors Product

Table 78. MolMed Revenue in Viral Vectors Business (2020-2025) & (US$ Million)

Table 79. MolMed Recent Development

Table 80. MassBiologics Company Details

Table 81. MassBiologics Business Overview

Table 82. MassBiologics Viral Vectors Product

Table 83. MassBiologics Revenue in Viral Vectors Business (2020-2025) & (US$ Million)

Table 84. MassBiologics Recent Development

Table 85. Richter-Helm Company Details

Table 86. Richter-Helm Business Overview

Table 87. Richter-Helm Viral Vectors Product

Table 88. Richter-Helm Revenue in Viral Vectors Business (2020-2025) & (US$ Million)

Table 89. Richter-Helm Recent Development

Table 90. FUJIFILM Diosynth Biotechnologies Company Details

Table 91. FUJIFILM Diosynth Biotechnologies Business Overview

Table 92. FUJIFILM Diosynth Biotechnologies Viral Vectors Product

Table 93. FUJIFILM Diosynth Biotechnologies Revenue in Viral Vectors Business (2020-2025) & (US$ Million)

Table 94. FUJIFILM Diosynth Biotechnologies Recent Development

Table 95. Lonza Company Details

Table 96. Lonza Business Overview

Table 97. Lonza Viral Vectors Product

Table 98. Lonza Revenue in Viral Vectors Business (2020-2025) & (US$ Million)

Table 99. Lonza Recent Development

Table 100. Aldevron Company Details

Table 101. Aldevron Business Overview

Table 102. Aldevron Viral Vectors Product

Table 103. Aldevron Revenue in Viral Vectors Business (2020-2025) & (US$ Million)

Table 104. Aldevron Recent Development

Table 105. Eurogentec Company Details

Table 106. Eurogentec Business Overview

Table 107. Eurogentec Viral Vectors Product

Table 108. Eurogentec Revenue in Viral Vectors Business (2020-2025) & (US$ Million)

Table 109. Eurogentec Recent Development

Table 110. Cell and Gene Therapy Catapult Company Details

Table 111. Cell and Gene Therapy Catapult Business Overview

Table 112. Cell and Gene Therapy Catapult Viral Vectors Product

Table 113. Cell and Gene Therapy Catapult Revenue in Viral Vectors Business (2020-2025) & (US$ Million)

Table 114. Cell and Gene Therapy Catapult Recent Development

Table 115. Biovian Company Details

Table 116. Biovian Business Overview

Table 117. Biovian Viral Vectors Product

Table 118. Biovian Revenue in Viral Vectors Business (2020-2025) & (US$ Million)

Table 119. Biovian Recent Development

Table 120. Thermo Fisher Scientific (Brammer Bio) Company Details

Table 121. Thermo Fisher Scientific (Brammer Bio) Business Overview

Table 122. Thermo Fisher Scientific (Brammer Bio) Viral Vectors Product

Table 123. Thermo Fisher Scientific (Brammer Bio) Revenue in Viral Vectors Business (2020-2025) & (US$ Million)

Table 124. Thermo Fisher Scientific (Brammer Bio) Recent Development

Table 125. VGXI Company Details

Table 126. VGXI Business Overview

Table 127. VGXI Viral Vectors Product

Table 128. VGXI Revenue in Viral Vectors Business (2020-2025) & (US$ Million)

Table 129. VGXI Recent Development

Table 130. PlasmidFactory Company Details

Table 131. PlasmidFactory Business Overview

Table 132. PlasmidFactory Viral Vectors Product

Table 133. PlasmidFactory Revenue in Viral Vectors Business (2020-2025) & (US$ Million)

Table 134. PlasmidFactory Recent Development

Table 135. Research Programs/Design for This Report

Table 136. Key Data Information from Secondary Sources

Table 137. Key Data Information from Primary Sources

Table 138. Authors List of This Report

List of Figures

Figure 1. Viral Vectors Picture

Figure 2. Global Viral Vectors Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Viral Vectors Market Share by Type: 2024 VS 2031

Figure 4. Retroviral Vectors Features

Figure 5. Lentiviral Vectors Features

Figure 6. Adenoviral Vectors Features

Figure 7. Herpes Simplex Virus Vectors Features

Figure 8. Chimeric Viral Vectors Features

Figure 9. Others Features

Figure 10. Global Viral Vectors Market Size by Application (2020-2031) & (US$ Million)

Figure 11. Global Viral Vectors Market Share by Application: 2024 VS 2031

Figure 12. Cancers Case Studies

Figure 13. Inherited Disorders Case Studies

Figure 14. Viral Infections Case Studies

Figure 15. Others Case Studies

Figure 16. Viral Vectors Report Years Considered

Figure 17. Global Viral Vectors Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 18. Global Viral Vectors Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 19. Global Viral Vectors Market Share by Region: 2024 VS 2031

Figure 20. Global Viral Vectors Market Share by Players in 2024

Figure 21. Global Top Viral Vectors Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Viral Vectors as of 2024)

Figure 22. The Top 10 and 5 Players Market Share by Viral Vectors Revenue in 2024

Figure 23. North America Viral Vectors Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 24. North America Viral Vectors Market Share by Country (2020-2031)

Figure 25. United States Viral Vectors Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. Canada Viral Vectors Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. Europe Viral Vectors Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. Europe Viral Vectors Market Share by Country (2020-2031)

Figure 29. Germany Viral Vectors Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. France Viral Vectors Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. U.K. Viral Vectors Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Italy Viral Vectors Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Russia Viral Vectors Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. Nordic Countries Viral Vectors Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. Asia-Pacific Viral Vectors Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. Asia-Pacific Viral Vectors Market Share by Region (2020-2031)

Figure 37. China Viral Vectors Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Japan Viral Vectors Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. South Korea Viral Vectors Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. Southeast Asia Viral Vectors Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. India Viral Vectors Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Australia Viral Vectors Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Latin America Viral Vectors Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Latin America Viral Vectors Market Share by Country (2020-2031)

Figure 45. Mexico Viral Vectors Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. Brazil Viral Vectors Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. Middle East & Africa Viral Vectors Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 48. Middle East & Africa Viral Vectors Market Share by Country (2020-2031)

Figure 49. Turkey Viral Vectors Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 50. Saudi Arabia Viral Vectors Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 51. UAE Viral Vectors Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 52. BioReliance Revenue Growth Rate in Viral Vectors Business (2020-2025)

Figure 53. Cobra Biologics Revenue Growth Rate in Viral Vectors Business (2020-2025)

Figure 54. Oxford BioMedica Revenue Growth Rate in Viral Vectors Business (2020-2025)

Figure 55. UniQure Revenue Growth Rate in Viral Vectors Business (2020-2025)

Figure 56. FinVector Revenue Growth Rate in Viral Vectors Business (2020-2025)

Figure 57. MolMed Revenue Growth Rate in Viral Vectors Business (2020-2025)

Figure 58. MassBiologics Revenue Growth Rate in Viral Vectors Business (2020-2025)

Figure 59. Richter-Helm Revenue Growth Rate in Viral Vectors Business (2020-2025)

Figure 60. FUJIFILM Diosynth Biotechnologies Revenue Growth Rate in Viral Vectors Business (2020-2025)

Figure 61. Lonza Revenue Growth Rate in Viral Vectors Business (2020-2025)

Figure 62. Aldevron Revenue Growth Rate in Viral Vectors Business (2020-2025)

Figure 63. Eurogentec Revenue Growth Rate in Viral Vectors Business (2020-2025)

Figure 64. Cell and Gene Therapy Catapult Revenue Growth Rate in Viral Vectors Business (2020-2025)

Figure 65. Biovian Revenue Growth Rate in Viral Vectors Business (2020-2025)

Figure 66. Thermo Fisher Scientific (Brammer Bio) Revenue Growth Rate in Viral Vectors Business (2020-2025)

Figure 67. VGXI Revenue Growth Rate in Viral Vectors Business (2020-2025)

Figure 68. PlasmidFactory Revenue Growth Rate in Viral Vectors Business (2020-2025)

Figure 69. Bottom-up and Top-down Approaches for This Report

Figure 70. Data Triangulation

Figure 71. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Viral Vector Vaccines Market Insights Forecast to 2030

Global Viral Vector Development Service Market Research Report 2025

Global Viral Vectors Non Viral Vectors and Gene Therapy Manufacturing Market Research Report 2024

Global Viral Vector Manufacturing Services Market Research Report 2024

Global Lentiviral Vectors Market Research Report 2024

Influenza Virus Vector Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Viral and Non Viral Vector Manufacturing Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Non viral Vectors Gene Therapy Market Research Report 2025

Global Viral Detection Market Research Report 2025

Viral Vector and Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Viral Vector Manufacturing Market Research Report 2024

Global Yeast Expression Vector Market Research Report 2024

Global Viral Vectors Gene Therapy Market Research Report 2025

Global Vector Database Market Research Report 2024

Global Virus Like Particles Market Research Report 2024

Global Virus Filters Market Research Report 2024

Global Vector Motor Market Research Report 2024

Lentiviral Vector Production System Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Adenovirus Vector Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions